| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $65,043,795 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 000 | 2 | NIH | 1/18/2024 | $368,242 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31HD108843 | Utilizing Causal X-Linked Intellectual Disability Variants to Gain Insight into the O-GlcNAc Transferase Enzyme | 001 | 2 | NIH | 6/3/2024 | $1,280 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31HD108843 | Utilizing Causal X-Linked Intellectual Disability Variants to Gain Insight into the O-GlcNAc Transferase Enzyme | 000 | 2 | NIH | 12/19/2023 | $47,694 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171346 | An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia | 001 | 2 | NIH | 5/21/2024 | $18,875 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171346 | An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia | 000 | 2 | NIH | 1/18/2024 | $169,875 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 001 | 2 | NIH | 5/2/2024 | $36,844 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 000 | 2 | NIH | 11/7/2023 | $331,600 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM149230 | Mechanism and Inhibition of Histone Modifications | 002 | 2 | NIH | 5/21/2024 | $37,297 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM149230 | Mechanism and Inhibition of Histone Modifications | 001 | 2 | NIH | 5/20/2024 | $29,319 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM149230 | Mechanism and Inhibition of Histone Modifications | 000 | 2 | NIH | 1/22/2024 | $335,675 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 002 | 2 | NIH | 8/5/2024 | $27,322 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 2 | NIH | 4/26/2024 | $67,936 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 2 | NIH | 1/18/2024 | $611,416 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173084 | Epitope and mechanistic correlates of broadly protective human antibodies for pneumococcal infection | 001 | 2 | NIH | 4/24/2024 | -$580,924 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173084 | Epitope and mechanistic correlates of broadly protective human antibodies for pneumococcal infection | 000 | 2 | NIH | 11/1/2023 | $653,539 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33MH121560 | Cognitive Training for Emotion Regulation in Psychotic Disorders | 000 | 3 | NIH | 7/11/2024 | $558,945 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 001 | 10 | NIH | 6/7/2024 | $37,769 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 000 | 10 | NIH | 1/17/2024 | $339,923 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HD112848 | Uterine epithelial ERα regulates preimplantation uterine immunity and sperm fitness | 000 | 1 | NIH | 7/16/2024 | $226,500 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL134899 | Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications | 001 | 7 | NIH | 7/11/2024 | $37,418 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL134899 | Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications | 000 | 7 | NIH | 12/21/2023 | $336,767 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI146857 | Dual oxidase and lactoperoxidase in influenza infection | 001 | 5 | NIH | 5/28/2024 | $37,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI146857 | Dual oxidase and lactoperoxidase in influenza infection | 000 | 5 | NIH | 1/19/2024 | $339,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG069196 | Cellular and circuit mechanisms underlying APOE-4 effects on olfaction. | 000 | 3 | NIH | 7/15/2024 | $1,091,036 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI179950 | Protein glycosylation and trafficking in Plasmodium falciparum | 001 | 1 | NIH | 9/4/2024 | $68,849 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI179950 | Protein glycosylation and trafficking in Plasmodium falciparum | 000 | 1 | NIH | 6/6/2024 | $632,390 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD114750 | Mechanisms of uterine fluid absorption during early pregnancy | 000 | 1 | NIH | 6/25/2024 | $685,199 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI185250 | Roles of C. albicans white-opaque regulators in biofilm and virulence | 001 | 1 | NIH | 9/11/2024 | $24,581 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI185250 | Roles of C. albicans white-opaque regulators in biofilm and virulence | 000 | 1 | NIH | 6/11/2024 | $221,231 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI180075 | Treatment outcome requirements for disease prevention in Chagas disease | 001 | 1 | NIH | 9/13/2024 | $63,353 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI180075 | Treatment outcome requirements for disease prevention in Chagas disease | 000 | 1 | NIH | 8/20/2024 | $582,938 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI180871 | Gene regulation in Cryptosporidium | 001 | 1 | NIH | 9/11/2024 | $23,056 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI180871 | Gene regulation in Cryptosporidium | 000 | 1 | NIH | 6/14/2024 | $207,518 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181461 | Understanding Plasmodium falciparum's multidrug resistance protein through the characterization of a novel antimalarial class. | 001 | 1 | NIH | 5/8/2024 | $1,280 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK140275 | Diet and the neurodevelopment of impulsivity | 000 | 1 | NIH | 8/1/2024 | $615,411 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | H79SP082105 | Project NaviGAte: Connecting Georgia to Substance Use and HIV Prevention | 002 | 5 | SAMHSA | 7/30/2024 | $199,889 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181461 | Understanding Plasmodium falciparum's multidrug resistance protein through the characterization of a novel antimalarial class. | 000 | 1 | NIH | 12/8/2023 | $47,694 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL161094 | Role of POGLUT2 and POGLUT3 in regulating microfibril structure and function | 000 | 3 | NIH | 8/1/2024 | $673,668 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS134272 | Characterizing genes that regulate dopaminergic neuron regeneration in the planarian brain | 001 | 1 | NIH | 6/10/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181492 | The impact of the mosquito gut microbiota on regulation of egg formation and malaria infection | 000 | 1 | NIH | 7/10/2024 | $48,974 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AI148114 | Composition and structure of antibody receptors at the surface of primary human cells during immune activation | 000 | 5 | NIH | 5/17/2024 | $381,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS134272 | Characterizing genes that regulate dopaminergic neuron regeneration in the planarian brain | 000 | 1 | NIH | 6/10/2024 | $33,629 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM147209 | Spatial genetics investigation of multinucleated cells | 000 | 3 | NIH | 8/7/2024 | $377,500 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171727 | The activation of benzoxaborole prodrug AN15368, a clinical candidate for Chagas disease | 001 | 2 | NIH | 5/22/2024 | $18,875 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171727 | The activation of benzoxaborole prodrug AN15368, a clinical candidate for Chagas disease | 000 | 2 | NIH | 1/24/2024 | $169,875 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 2 | NIH | 12/14/2023 | $595,384 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 001 | 2 | NIH | 5/21/2024 | $66,154 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21GM149588 | Photochemical Technologies for Improved Glycosylation Reactions | 000 | 2 | NIH | 5/16/2024 | $179,694 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA257851 | Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer | 000 | 4 | NIH | 5/29/2024 | $503,511 |
|
